Effects of Esomeprazole on the Pharmacokinetics of Lapatinib in Breast Cancer Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|2|4|336-341

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 336-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to lapatinib appears to be affected by HER protein expression in patients with inflammatory breast cancer

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Lapatinib for breast cancer: a review of the current literature

By MacFarlane Robyn J   Gelmon Karen A  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 109-121

Informa Healthcare

Access to resources Recommend Favorite

Lapatinib no help in HER-2-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Lapatinib may be active in urogenital, breast cancer

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Novel Approaches to Advanced Breast Cancer: Bevacizumab and Lapatinib

By Mayer Erica L.   Lin Nancy U.   Burstein Harold J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 3, 2007-03 ,pp. : 314-323

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite